Key result
Autoantibodies targeting cardiac calcium channels drive the development of cardiac electrical abnormalities.
Why the study?
Patients with autoimmune diseases are at increased risk for cardiovascular diseases and abnormal electrocardiographic findings, with emerging evidence implicating calcium channels as autoantibody targets.
This review highlights the emerging role of autoimmune-associated calcium channelopathies as a mechanism for cardiac arrhythmias in conditions like dilated cardiomyopathy and congenital heart block.
Patients with autoimmune diseases are at increased risk for developing cardiovascular diseases, and abnormal electrocardiographic findings are common. Voltage-gated calcium channels play a major role in the cardiovascular system and regulate cardiac excitability and contractility. Particularly, by virtue of their localization and expression in the heart, calcium channels modulate pace making at the sinus node, conduction at the atrioventricular node and cardiac repolarization in the working myocardium. Consequently, emerging evidence suggests that calcium channels are targets to autoantibodies in autoimmune diseases. Autoimmune-associated cardiac calcium channelopathies have been recognized in both sinus node dysfunction atrioventricular block in patients positive for anti-Ro/La antibodies, and ventricular arrhythmias in patients with dilated cardiomyopathy. In this review, we discuss mechanisms of autoimmune-associated calcium channelopathies and their relationship with the development of cardiac electrical abnormalities.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2019) conducted a review in Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities. Autoantibodies targeting cardiac calcium channels, including anti-Ro and anti-α1C antibodies, play a critical pathogenic role in the development of cardiac electrical abnormalities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: